SCHEMBL31474329

SCHEMBL31474329

CNC(=O)c1cnc(N2CCNCC2)s1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 13/20 0.56
HDAC3 O15379 11/20 0.56
HDAC1 Q13547 9/20 0.56
HDAC4 P56524 7/20 0.56
HDAC7 Q8WUI4 7/20 0.56
HDAC10 Q969S8 7/20 0.56
HDAC11 Q96DB2 7/20 0.56
HDAC8 Q9BY41 7/20 0.56
HDAC6 Q9UBN7 7/20 0.56
HDAC9 Q9UKV0 7/20 0.56
HDAC5 Q9UQL6 7/20 0.56
SCD O00767 1/20 0.54
CYP1A2 P05177 1/20 0.53
CYP2C18 P33260 1/20 0.53
CYP2C19 P33261 1/20 0.53
KCNH2 Q12809 1/20 0.53
OGA O60502 3/20 0.52
SNCA P37840 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29215320 0.99 HDAC2 (0.54) HDAC2HDAC3HDAC1HDAC4HDAC7
SCHEMBL4092990 0.83 CRBN (0.55) HDAC2HDAC3HDAC1HDAC4HDAC7
SCHEMBL2146195 0.82 HDAC2 (0.52) HDAC2HDAC3HDAC1HDAC4HDAC7
SCHEMBL4087186 0.81 SCD (0.51) HDAC2HDAC3HDAC1HDAC4HDAC7
Hydrochloric Acid SCHEMBL2828121 0.79 HDAC2 (0.45) HDAC2HDAC3HDAC1HDAC4HDAC7
Hydrochloric Acid SCHEMBL2831916 0.79 HDAC2 (0.45) HDAC2HDAC3HDAC1HDAC4HDAC7
SCHEMBL21771311 0.79 SCD (0.55) HDAC2HDAC3HDAC1HDAC4HDAC7
SCHEMBL28539361 0.77 HDAC2 (0.47) HDAC2HDAC3HDAC1HDAC4HDAC7
SCHEMBL5334339 0.77 OGA (0.55) HDAC2HDAC3HDAC1HDAC4HDAC7
SCHEMBL5224561 0.76 HDAC2 (0.76) HDAC2HDAC3HDAC1HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250346573-A1 AZAQUINOLINONE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF CHENGDU EASTON BIOPHARMACEUTICALS CO LTD (CN) 2025-11-13 US disclosed
EP-4534533-A1 AZAQUINOLINONE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF Chengdu Easton Biopharmaceuticals Co., Ltd. (CN) 2025-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250346573-A1 AZAQUINOLINONE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF PARP1, PARP8, PARP11 HDAC2 482/4885HDAC3 1400/4885HDAC1 227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.